HuMMANet provides a standardized framework for reproducible microbiome–metabolome integration, enabling cross-study discovery and translational prioritization of conserved microbiome-derived metabolic signatures across human populations and disease states.
Abstract
Deciphering gut-microbiome–to–host-metabolome interaction is critical for understanding how microbial communities generate bioactive signals that shape host physiology and disease. Progress, however, has been hindered by inconsistent metabolite annotations, poor interoperability across studies, and the absence of integrated resources placing microbiome-derived metabolites within their functional, microbial, physiological, and clinical context. Here we present HuMMANet (Human Microbiome–Metabolome Annotation Network), a harmonized resource integrating 46 paired gut microbiome–metabolome studies (59 study-units; 14,405 samples; 13 disease categories plus a healthy/control reference category) with a scalable metabolite-harmonization framework. HuMMANet resolves heterogeneous annotations through a multi-stage workflow spanning RefMet, HMDB, PubChem, Metabolomics Workbench, SMPDB, MiMeDB-2.0, GNPS/microbeMASST, DrugBank, and DrugCentral, yielding a reference atlas of 54,914 unique metabolites, annotated with standardized chemical identifiers, biochemical pathways, microbial producer associations, physiological distributions, disease links, and structural relationships to approved therapeutics — a unified reference framework for microbiome– metabolome research. Applying HuMMANet to a multi-cohort integration of adult serum and fecal metabolomes, we identified 519 serum and 322 fecal metabolites reproducibly associated with gut microbial community composition (PERMANOVA, P < 0.05 in at least 50% of studies in which detected), enriched for specific biomolecular classes and pathways. Cross-referencing these against Health-Associated-Core-Keystone (HACK) taxa revealed 58 serum and 25 fecal metabolites (HACK-positive) whose taxon-level associations tracked positively with the taxon-specific-HACK indices. These reproducible metabolomic signatures of microbiome health included indole-3-propionic acid, a gut barrier-protective microbial tryptophan metabolite, and 3-phenylpropionate. Drug-similarity annotation within HuMMANet linked 16 of this serum and 13 fecal HACK-positive metabolites to therapeutics used in neurological, inflammatory, and vascular disease. Conversely, 38 serum and 65 fecal metabolites, including imidazole propionate and long-chain acylcarnitines such as ACar 18:0, showed HACK-negative signatures previously associated with dysbiosis-linked disease. GNPS/microbeMASST and MiMeDB-2.0 annotations further traced subsets of these metabolites to putative bacterial producers. HuMMANet thus provides a standardized framework for reproducible microbiome–metabolome integration, enabling cross-study discovery and translational prioritization of conserved microbiome-derived metabolic signatures across human populations and disease states.
Application to a human sample from a patient with type 2 Diabetes Mellitus recovered a dysbiotic signature consistent with the literature, including reduced Firmicutes abundance, elevated Bacteroidetes and Proteobacteria, and a predominance of clinical associations within metabolic and gastrointestinal categories.
Rodrigo Lima Andrade, Tayná da Silva Fiúza, J. Kroll et al.· bioRxiv· 0 citations
This work leverage 1,150 complete genomes to construct genome-scale metabolic models, demonstrating that draft assemblies introduce systematic artifacts and omit critical transport functions, and connects genome completeness with microbial ecological organization and provides a framework for linking metabolic interactions to microbiome-associated disease.
Yu-He Gu, Haoyu Wang, Jin-Long Yang et al.· Cell Reports· 0 citations
The gut microbiome shapes systemic physiology through metabolites that enter circulation, yet most computational approaches focus on predicting metabolite profiles from microbial features rather than inferring microbial composition from host metabolomes. Here, we investigate whether host-derived metabolomic profiles can be leveraged to predict gut microbial community structure and to determine how disease-associated dysbiosis reshapes metabolite-microbe interactions and gut-to-systemic metabolic communication. We developed an integrative multi-omics framework combining serum and cecal metabolomics with 16S rRNA-based microbiome profiling. Supervised learning models demonstrated that cecal metabolites carry predictive signals for microbial abundances across conditions. Regularized canonical correlation analysis (rCCA) revealed cross-compartment metabolite-microbe networks. These analyses showed both conserved and condition-specific interaction patterns, indicating substantial network reorganization under disease-associated dysbiosis. Pathway-level integration further identified metabolic pathways linking the gut microbiome, the cecal environment, and the systemic circulation, representing coordinated gut-to-systemic communication axes. Together, our results establish a multi-omics strategy for predictive inference of gut microbial composition from host metabolomes and provide a framework for identifying pathway-level mechanisms underlying host-microbe metabolic crosstalk.
Multi-omics approaches have revolutionized our understanding of microbial communities by enabling simultaneous interrogation of genomic, transcriptomic, proteomic, and metabolomic data. The systematic integration and analysis of these deep datasets help decipher the functional roles of microbiomes, providing critical insights into microbial activities, interactions, and dynamics across diverse environments. Biological complexity makes multi-omics analysis of a single, isolated organism demanding but highly informative, yet this complexity increases further when samples comprise hundreds to thousands of individual species. As microbiome research continues to expand into clinical, environmental, and engineered systems, standardized workflows, benchmarked datasets, and community-driven initiatives are essential to ensure reproducibility, standardization and interpretability. Establishing and disseminating best practices for experimental design, data processing, and integrative analyses will be critical for maximizing comparability and scientific rigor across studies. This perspective highlights recent advances in multi-omics microbiome research, outlines key obstacles in data integration and metadata harmonization, and proposes a collaborative roadmap for scalable, FAIR-compliant multi-omics investigations and potentially disruptive Artificial Intelligence (AI) advances comparable to those of AlphaFold in the field of microbiome science. In this Perspective, the authors discuss recent advances in multi-omics microbiome research, outlining key obstacles in data integration and metadata harmonization, and proposing a roadmap for scalable, FAIR-compliant multi-omics investigations and potentially disruptive Artificial Intelligence advances.
T. Van Den Bossche, Eunice Lazau, Velma T. E. Aho et al.· Nature Communications· 0 citations
This review offers a thorough overview of both current and emerging methods for studying the gut microbiome, including sample collection techniques, culture-based approaches like culturomics and microfluidics, as well as culture-independent methods such as 16S rRNA sequencing, shotgun metagenomics, and the integration of multi-omics approaches like metabolomics, proteomics, and transcriptomics.
Divya Kaki, Uday Kore, Anusha Talari et al.· Journal of Microbiological M...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.